Background
Intensive care unit acquired weakness (ICUAW) is a general term that integrates the clinical and pathophysiological aspects of symmetric distal axonal neuropathy (CIP) and proximal myopathy (CIM) related to an intensive care therapy. ICUAW is common in intensive care patients (up to 82% of patients) and is an independent risk factor for long-term disability and a reduced quality of life in ICU survivors [
1‐
3]. CIM is thought to be the result of muscle protein breakdown and myofiber necrosis due to inflammatory systemic responses and inactivity [
4‐
6]. In contrast to CIP, CIM is usually transient and resolves during rehabilitation. In CIP systemic toxins, inflammatory responses, endothelial changes in sepsis as well as vasoactive and other medication are prone to cause microvascular damage and toxic axonal degeneration that is often non-reversible and cause long-lasting clinical deficits [
7]. Thus, ICUAW can be regarded as an organ failure of the peripheral neuromuscular system with a high impact on long-term disability [
1,
2].
Long-term data of ICU survivors are rare. A 5-year follow-up revealed a reduced motor performance and quality of life [
3,
8‐
10]. Thus, objective outcome measures are highly important to quantify the disease status of the patients. For the measurement of disability, especially in CIP—since it contributes mainly to long-lasting dysfunction—MRC grading, walking tests, electrophysiologic testing, quality of life questionnaires and patients functional status have been used [
1,
2,
10‐
13].
Van Aerde et al. showed that even a slight reduction in MRC sum score could be associated with a high 5-year morbidity and mortality after ICU discharge and underline the importance to capture muscle degeneration early [
14]. Imaging studies in ICUAW mostly relate to computed tomography (CT) and muscle ultrasound (US) where a reduction in muscle mass and a change in muscle composition can reflect muscle degeneration due to ICUAW [
15‐
19]. While both modalities are easy to access and feasible to use for a comprehensive muscle status in the acute setting of an ICU therapy, they are unable quantify muscle status in terms of fatty infiltration and muscle architecture in the long-term evaluation of ICU survivors [
2,
15,
20]. Diagnosing ICU related polyneuropathy is standardized with electrophysiologic testing (EMG). However, ongoing long term muscle degeneration and myoarchitectural changes cannot be captured with it. Diagnostic MRI is the current gold-standard to evaluate the extend of acute and chronic muscle damage in neuropathies and myopathies and quantitative MR imaging (qMRI) protocols are increasingly used in neuromuscular research [
21,
22]. qMRI markers such as mDixon fat-fraction, muscle diffusion tensor imaging and water T2 are established objective outcome measures to grade muscle degeneration and correlate with clinical muscle function [
23‐
25]. Using mDixon sequences fatty infiltration can be objectively quantified, T2 mapping allows to capture muscle oedema and inflammation via water T2 relaxation time and mDTI can reveal myofiber atrophy on a microstructural level [
25‐
29]. The result pattern of qMRI outcome measures allows conclusions on pathomechanisms of muscle degeneration and its classification as acute or chronic. Thus, an increased water T2 time reflects active muscle degeneration due to tissue edema, a fatty muscle infiltration can be measured with mDixon and reflects chronic muscle damage, and muscle fiber atrophy can be captured with the mDTI sequences [
25‐
27]. Until now, there are no studies on long-term ICU survivors with or without ICUAW regarding qMRI evaluation. The aim of this study was to comprehensively evaluate the quality and quantity of structural muscle differences in long-term ICU survivors with a qMRI protocol and to correlate them to clinical findings and quality of life questionnaires. Better understanding of the long-lasting myoarchitectural abnormalities may contribute to optimized treatment options in the rehabilitation phase.
Methods
Study population
The subjects in the present study were part of a larger study (CRIT-Path study) with the aim to investigate the incidence of clinical and electrophysiological abnormalities in long-term ICU survivors. Subjects evaluated in the present study additionally underwent qMRI. Based on a medical patient management database screening, patients admitted to ICU between 2007 and 2017, (≥ 7d on ICU of an university hospital including ≥ 3d of invasive ventilation, at least 6mo-10y post-ICU, aged ≤ 85y) were contacted by letter [
3]. Volunteers then called the study centre to authorise study participation (see Table
1 for details). Sex- and age-matched controls without history of ICU treatment, neuromuscular diseases (NMD) or injuries in lower extremity 12 months before study enrolment were recruited via advertisement. MRI exclusion criteria were metal implants in lower legs or back or electronical implants such as a cochlear implant or drug pumps. This prospective study had been approved by the local ethics committee of the Ruhr-University Bochum (No. 4905-14 3.0) and written informed consent for participation and publication was obtained from all participants prior to enrolment.
CP 1 | 77 | 187 | 94 | 26.88 | 10 | 95 | 1240 | Hypertension, Coronary artery disease, obstructive sleep apnea |
CP 2 | 30 | 190 | 87 | 24.10 | 15 | 270 | 771 | none |
CP 3 | 60 | 168 | 81 | 28.70 | 83 | 1848 | 712 | Hypertension, Coronary artery disease |
CP 4 | 64 | 160 | 129 | 50.39 | 15 | 209 | 2422 | Type-II-diabetes. Hyper-tension. Hypothyreoidism |
CP 5 | 54 | 178 | 138 | 43.56 | 19 | 369 | 965 | Hypertension, Atrial fibrillation. Hypothyreoidism |
CP 6 | 41 | 179 | 67 | 20.91 | 30 | 586 | 90 | Hypertension. Coronary artery disease |
CP 7 | 47 | 186 | 83 | 23.99 | 42 | 240 | 6022 | none |
CP 8 | 73 | 167 | 70 | 25.10 | 8 | 127 | 3588 | Hypertension, Hyperthyroidism, Coronary artery disease |
CP 9 | 77 | 168 | 81 | 28.70 | 18 | 180 | 2555 | Hypertension, Hypothyreoidism |
Clinical and electrophysiological assessments
Muscle strength was evaluated using the Medical Research Council (MRC; 0–60) by an experienced clinician. Grip strength was measured with a hand dynamometer on both hands [
30]. Quality of life was measured with the EuroQOL5-Dimension questionnaire (EQ-5D-3L VAS). Subjects were assessed for any typical ICUAW symptoms like symmetrical proximal muscle weakness, distal dysesthesia, paraesthesia or pain (see Table
2 for details).
CP 1 | Y | 23 | 9 | 54 | 2.2 | 0 | Axonal | 50 |
CP 2 | N | 54 | 56 | 59 | 2.8 | 1.37 | Mixed axonal demyelinating | 90 |
CP 3 | Y | 23 | 29 | 50 | 4.7 | 6.7 | Mixed axonal demyelinating | 50 |
CP 4 | N | 20 | 23 | 60 | 0 | 0 | Axonal | 100 |
CP 5 | Y | 24 | 21 | 56 | 3 | 4.2 | Mixed axonal demyelinating | 30 |
CP 6 | Y | 11 | 12 | 52 | 7.1 | 8.7 | Demyelinating | 35 |
CP 7 | Y | 39 | 26 | 58 | 8.8 | 15.3 | Small fiber neuropathy | 75 |
CP 8 | Y | 28 | 30 | 60 | 8.5 | 9.5 | Axonal in electromyography | 90 |
CP 9 | Y | 32 | 28 | 59 | 2.1 | 0.83 | Mixed axonal demyelinating | 50 |
Electroneurography (ENG) was done unilaterally for the sural, the peroneal, the tibial and the ulnar nerve. For this study, we report tibial nerve compound motor action potential (TNCMAP) and sural nerve sensory action potential (SNSNAP). Polyneuropathy was graded as either axonal, demyelinating or combined based on the definition by England et al. [
31] Electromyography (EMG) was performed unilaterally in the anterior tibialis and the vastus lateralis muscle and graded as abnormal in terms of acute, subacute or chronic neurogenic damage according to Mills [
32].
MRI acquisition and sequences
MR scans of both legs vertical to the femur and tibia bone were obtained using a Philips 3.0T Achieve MR system and a 16CH Torso XL coil. The participants lay in a feet-first supine position. Cushions were used to support participants’ knees and sandbags placed around their feet to prevent motion.
For the first MRI acquisition protocol (first four patients) the thigh region from hip to knee was split into three fields of view (FOV) along the z-axis with a 30 mm overlap, which each FOV comprised T1-weighted (T1w), T2-weighted (T2w), a diffusion-weighted spin-echo EPI (voxel size 3.0 × 3.0 × 6.0 mm
3; TR/TE 5000/57 ms; SPAIR/SPIR fat suppression; SENSE: 1.9; 17 gradient directions with b-values of 400 and 3 images with b-value of 0 [
33] as well as one noise measurement (by turning of the RF and imaging gradients) with a total acquisition time of approximately 27 min for both thighs (9 min per FOV). An additional mDixonquant sequence (voxel size 1.5 × 1.5 × 6.0 mm
3; TR/TE 210/2.6, 3.36, 4.12, 4.88 ms; flip angle 8°, SENSE: 2) was acquired. After the image acquisition of the thigh-regions the data acquisition was paused and the TorsoXL coil was wrapped around the lower leg region; the calf region was split into two fields of view for additional 18 min scanning time for both calves.
The protocol for the remaining five patients consisted of a 4-point Dixon sequence (voxel size 1.5 × 1.5 × 6.0 mm
3; TR/TE 210/2.6, 3.36, 4.12, 4.88 ms; flip angle 8°, SENSE: 2), a multi‐echo spin‐echo (MESE) sequence for quantitative water mapping including 17 echoes and Cartesian k‐space sampling (voxel size 3.0 × 3.0 × 6.0 mm
3; TR/TE 4598/17x∆7.6 ms; flip angle 90/180°, SENSE: 2), and a diffusion-weighted spin-echo EPI (voxel size 3.0 × 3.0 × 6.0 mm
3; TR/TE 5000/57 ms; SPAIR/SPIR fat suppression; SENSE: 1.9; 42 gradient directions with eight different b-values (0–600) [
33]. A noise scan was obtained as described above. Here both, the thigh and the calf regions were both split into two fields of view each and the scanning time per stack was approximately 12 min.
Data pre-processing
Data from the first protocol were analysed as described previously in Schlaffke et al. [
34,
35] Data from the second protocol were pre-processed as described before using QMRITools (
www.qmritools.com) [
33] In brief, the diffusion data were denoised using a PCA method [
36]. To correct for subject motion and eddy currents both legs were registered separately. Then the tensors were calculated by taking IVIM into account and using an iWLLS algorithm. A non-linear IVIM fit of the diffusion data was performed as described in Orton et al. [
37]. Furthermore, the IVIM bias signal was removed from diffusion weighted data using all acquired b-values [
38]. By using IVIM correction, an isotropic pseudo‐diffusion component was modelled in addition to the diffusion tensor, to effectively remove biases in mean diffusivity (MD) estimation.
However, if the pseudo‐diffusion process was anisotropic and aligned with the orientation of the muscle fibers, this would result in an increase in fractional anisotropy (FA) independently from the IVIM correction [
33,
39,
40]. The IDEAL method was used for the Dixon data considering a singleT2* decay and resulting in a separated water and fat map [
41]. The derived water maps were used for the manual segmentation. Considering different T2 relaxation times for the water and fat components the T2‐mapping data were processed using an extended phase graph (EPG) dictionary matching pattern method. Both water‐T2 relaxation time and transmit B1 (B1+) were fitted for each voxel using a dictionary method. The T2 of fat Rwas obtained according to Marty et al. [
42].
Muscle segmentation
Eight thigh muscles (vastus lateralis, vastus medialis, rectus femoris, semimembranosus, semitendinosus, biceps femoris, sartorius, and gracilis) and seven calf muscles (gastrocnemius medialis and lateralis, soleus, tibialis anterior, peroneus, extensor digitorum and tibialis posterior) were segmented manually avoiding subcutaneous fat and fascia on all slices of the reconstructed Dixon water images (3D-slicer 4.4.0,
https://www.Slicer.org) [
43].
The segmentations were then registered to T2 and DTI data to correct for small motions between sequences and image distortions using sequential rigid and b-spline transformations (elastix,
https://elastix.lumc.nl) [
44]. Average values within a muscle mask of water-T2 time (when available) and proton density fat fraction (FF) as well as the diffusion measures fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD) and axial diffusivity (λ
1) were obtained. SNR was calculated as the local average signal divided by the local noise sigma [
45].
Outliers
Due to motion artifacts, image inhomogeneities and two patients aborted scanning, thigh data were obtained for 4/9 patients. Calf MRI data could be obtained in all included patients.
Statistical analysis
Water T2, FF, FA, MD, RD and λ1 were compared between CIP patients and matched controls in a general linear model with patient/control as fixed factors as well as the protocol as nuisance variable, for all leg muscles.
To evaluate correlations between clinical assessments and qMRI values mean water T2, FF, FA, MD, RD and λ1 of all thigh and calf muscles were correlated to grip strength, MRC, TNCMAP, SNSNAP, EQ-5D-3L VAS as well as level of symptoms using Pearson’s correlation coefficients. All statistical analyses were performed using IBM SPSS V28. The significance level for all tests was set at p < 0.05.
Discussion
In this pilot study we show that qMRI values in leg muscles of patients after ICU treatment differ significantly from controls even years after ICU therapy and could reflect simultaneously muscle damage and chronic myostructural abnormalities [
27‐
29,
46]. Water T2 time and FA correlate negatively with MRC sum score, indicating the clinical relevance of our findings.
An elevated FF, as observed in our cohort, relates to chronic muscle degeneration and shows higher sensitivity compared to MRC testing and qualitative MRI in terms of capturing muscle degeneration in myopathies [
26,
47]. Fatty infiltration is a sign of previous muscle damage with fatty replacement of irreversible damaged muscle fibers [
48]. A high FF in muscle supports the hypothesis that long-term motor dysfunction and muscle fatigue in patients is caused by a myostructural deficit [
2,
3,
14,
49]. FF values were only slightly elevated in ICU survivors compared to controls and still in a “normal” range. Whereas FF describes fatty infiltration very accurately and is easy to capture as percent fat per muscle, changes in the other qMRI modalities DTI and water T2 need to be closely interpreted with the expected or known disease pathology.
Whereas CIM is transient and only reflects myostructural damage due to direct muscle injury in the acute phase of ICU therapy, CIP in contrast is long-lasting due to nerve injury and serves as the major cause of functional debilitation [
50]. Neurogenic myofiber atrophy due to axonal loss is usually irreversible and has already been described in muscle biopsies of CIP patients [
51].
Our electrophysiologic studies show predominantly axonal nerve damage in calf nerves of patients and clinical data underline that CIP usually affects distal limbs [
51]. Since we confirmed a polyneuropathy in our patient cohort, consistent with CIP, our observed differences of qMRI parameters reflect neurogenic muscle damage. The observed higher FA in patient muscles shows a higher proportion of axial compared to radial diffusion. In neurogenic myofiber atrophy, myofibers do not lose their structural integrity initially but get atrophic. This atrophy leads to myofiber diameter reduction and consequently to an increase in FA [
29,
52]. MD usually reflects the degree of overall diffusion as it equally integrates the eigenvalues λ
1- λ
3 as a simple mean value (MD =
\(\frac{\sum (\lambda 1, \lambda 2,\lambda 3)}{3}\)) and is elevated in active muscle degeneration and inflammation whereas a reduction of MD is seen in muscle atrophy without an active degeneration. The relation of MD and FA values is usually fixed [
29]. Thus a solely myofiber atrophy would lead to an increase in FA and a decrease in MD whereas an inflammatory edema would counterwise lead to a decrease in FA and an increase in MD (as well as RD, and λ
2–3) [
29]. Interestingly, in our patients, FA and MD are both significantly higher than in controls mostly pronounced in the calf muscles. A combination of a high FA and a high MD supports a parallel chronic myofiber atrophy and active myofiber degeneration.
Underlying active muscle fiber degeneration are revealed by a significantly elevated water T2 which is usually elevated in tissue with a higher content of fluid (e.g. inflammation, myofiber breakdown) [
53‐
55].
Thus, we hypothesize that our observed combination of unanimous elevated MD, water T2, FA and FF reflect parallel active muscle degeneration and myofiber atrophy in chronic damaged muscle tissue due to ICUAW. Although FF is significantly increased between the two groups, the absolute value is still comparably low, so that an influence of the FF on the DTI parameters can be ruled out [
56,
57]. This hypothesis is also underlined by a separate analysis of thigh and calf muscle qMRI values and by our clinical outcomes.
In thighs, compared to calves, chronic muscle degeneration is predominantly observed as MD is only mildly elevated compared to calves and water T2 is not elevated. In contrast, MD and water T2 are highly elevated in calves and reflect active muscle degeneration. Our data support that chronic axonal nerve damage in calves due to CIP leads to an ongoing myofiber damage and breakdown.
Correlations of FA and MD to clinical assessments have been described in myopathies before and the significant correlation of water T2 and FA to MRC values in our study additionally supports the relevance of qMRI values [
57,
58]. Since up to now there are no qMRI studies in long-term ICU survivors the presented results and the discussed pathophysiology is derived from known relations between quantitative muscle MRI parameters and myofiber degeneration. Reviews on ICUAW and known long-term data on ICU-survivors highlight the impact of motor status on long term quality of life [
59], since ICUAW and especially CIP affects peripheral nerves irreversibly and leads to ongoing neuromuscular complaints and a reduced ability to participate in daily life activities.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.